Insight Molecular Diagnostics Inc.

IMDX

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0001642380

SEC filings (opens in a new tab)

No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.

Superinvestors holding IMDX, Q2 2026

See all superinvestors

No superinvestor reported holding IMDX in Q2 2026.